Doug Schenkel
Stock Analyst at Wolfe Research
(2.85)
# 1,619
Out of 5,122 analysts
70
Total ratings
50%
Success rate
33.46%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Upgrades: Outperform | $60 | $42.56 | +40.98% | 3 | Dec 10, 2025 | |
| WAT Waters | Upgrades: Outperform | $480 | $384.33 | +24.89% | 2 | Dec 10, 2025 | |
| GH Guardant Health | Upgrades: Outperform | $75 | $106.15 | -29.35% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $21.84 | +46.52% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $53.55 | +12.04% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $74.59 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $48.12 | +24.69% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $15.09 | +85.55% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $237.05 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $146.11 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $3.27 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $285 | $219.53 | +29.82% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $132.98 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $49 | $51.71 | -5.14% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $19.06 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $134.19 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $102.27 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $565.22 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.30 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $103.83 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.95 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $11.14 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $205.61 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.00 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.91 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.63 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.34 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.81 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $32.94 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $1.32 | +1,263.64% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $18.99 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $251.24 | -64.18% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.32 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $176.49 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $70.82 | -77.41% | 2 | Sep 28, 2017 |
Bruker
Dec 10, 2025
Upgrades: Outperform
Price Target: $60
Current: $42.56
Upside: +40.98%
Waters
Dec 10, 2025
Upgrades: Outperform
Price Target: $480
Current: $384.33
Upside: +24.89%
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $106.15
Upside: -29.35%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $21.84
Upside: +46.52%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $53.55
Upside: +12.04%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $74.59
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $48.12
Upside: +24.69%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $15.09
Upside: +85.55%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $237.05
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $146.11
Upside: -
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.27
Upside: -
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $219.53
Upside: +29.82%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $132.98
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $49
Current: $51.71
Upside: -5.14%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $19.06
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $134.19
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $102.27
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $565.22
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $5.30
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $103.83
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.95
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $11.14
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $205.61
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.00
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.91
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.63
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.34
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.81
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $32.94
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $1.32
Upside: +1,263.64%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $18.99
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $251.24
Upside: -64.18%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $6.32
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $176.49
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $70.82
Upside: -77.41%